These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 22426675)

  • 21. Preliminary report of patients with meningiomas exposed to Cyproterone Acetate, Nomegestrol Acetate and Chlormadinone Acetate - Monocentric ongoing study on progestin related meningiomas.
    Devalckeneer A; Aboukais R; Bourgeois P; De Witte O; Racape J; Caron S; Perbet R; Maurage CA; Lejeune JP
    Clin Neurol Neurosurg; 2021 Nov; 210():106959. PubMed ID: 34592677
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Presentation of a meningioma in a transwoman after nine years of cyproterone acetate and estradiol intake: case report and literature review.
    Mancini I; Rotilio A; Coati I; Seracchioli R; Martelli V; Meriggiola MC
    Gynecol Endocrinol; 2018 Jun; 34(6):456-459. PubMed ID: 29105524
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of Hormonal Contraception with Meningioma Location in Indonesian Patients.
    Malueka RG; Hartanto RA; Setyawan NH; Fauzi DNF; Damarjati KR; Rismawan A; Septianastiti MA; Wicaksono AS; Dananjoyo K; Basuki E; Asmedi A; Dwianingsih EK
    Asian Pac J Cancer Prev; 2022 Mar; 23(3):1047-1051. PubMed ID: 35345379
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abrupt regression of a meningioma after discontinuation of cyproterone treatment.
    Gonçalves AM; Page P; Domigo V; Méder JF; Oppenheim C
    AJNR Am J Neuroradiol; 2010 Sep; 31(8):1504-5. PubMed ID: 20053802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hormonal effect on meningioma growth.
    Shahar T; Ram Z
    World Neurosurg; 2011 Nov; 76(5):412-4. PubMed ID: 22152568
    [No Abstract]   [Full Text] [Related]  

  • 26. Gender-affirming hormone therapy associated with multiple meningiomas and atypical histology in a transgender woman.
    Millward CP; Phillips E; Alalade AF; Gilkes CE
    BMJ Case Rep; 2021 Jul; 14(7):. PubMed ID: 34261631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Luteinizing hormone-releasing hormone agonists and meningioma: a treatment dilemma.
    Lee KL; Terris MK
    Urology; 2003 Aug; 62(2):351. PubMed ID: 12893358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regression of multiple intracranial meningiomas after cessation of long-term progesterone agonist therapy.
    Vadivelu S; Sharer L; Schulder M
    J Neurosurg; 2010 May; 112(5):920-4. PubMed ID: 19731987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Meningioma and hormonal influences.
    Wahab M; Al-Azzawi F
    Climacteric; 2003 Dec; 6(4):285-92. PubMed ID: 15006250
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A systematic review and meta-analysis of the association between cyproterone acetate and intracranial meningiomas.
    Lee KS; Zhang JJY; Kirollos R; Santarius T; Nga VDW; Yeo TT
    Sci Rep; 2022 Feb; 12(1):1942. PubMed ID: 35121790
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Meningeal melanocytoma or multiple pigmented meningioma of the spinal canal. Report of a case. Review of the literature].
    Crouzet J; Richard S; Pillet G; Muckensturm B; Srour A; Pradat P
    Rev Rhum Mal Osteoartic; 1992 Nov; 59(11):738-43. PubMed ID: 1306593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Meningioma-toward an improved understanding of the role of sex steroids in tumor development and progression.
    Elder JB; Chiocca EA
    World Neurosurg; 2011 Nov; 76(5):409-11. PubMed ID: 22152567
    [No Abstract]   [Full Text] [Related]  

  • 33. Regression of meningiomas after discontinuation of cyproterone acetate in a transsexual patient.
    Cebula H; Pham TQ; Boyer P; Froelich S
    Acta Neurochir (Wien); 2010 Nov; 152(11):1955-6. PubMed ID: 20811919
    [No Abstract]   [Full Text] [Related]  

  • 34. Meningioma.
    Marosi C; Hassler M; Roessler K; Reni M; Sant M; Mazza E; Vecht C
    Crit Rev Oncol Hematol; 2008 Aug; 67(2):153-71. PubMed ID: 18342535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemical expression of aromatase and estrogen, androgen and progesterone receptors in normal and neoplastic human meningeal cells.
    Leães CG; Meurer RT; Coutinho LB; Ferreira NP; Pereira-Lima JF; da Costa Oliveira M
    Neuropathology; 2010 Feb; 30(1):44-9. PubMed ID: 19703265
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progesterone receptors are expressed with higher frequency by optic nerve sheath meningiomas.
    Thom M; Martinian L
    Clin Neuropathol; 2002; 21(1):5-8. PubMed ID: 11846045
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two subtypes of meningiomas with different imaging co-existed at sphenoid ridge.
    Ge PF; Fu SL; Liu DH; Zhong YP; Luo YN
    Br J Neurosurg; 2010 Dec; 24(6):720-1. PubMed ID: 20649407
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sex steroid and epidermal growth factor profile of giant meningiomas associated with pregnancy.
    Hatiboglu MA; Cosar M; Iplikcioglu AC; Ozcan D
    Surg Neurol; 2008 Apr; 69(4):356-62; discussion 362-3. PubMed ID: 17707480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spontaneous postpartum resolution of vision loss caused by a progesterone receptor-positive tuberculum sellae meningioma.
    Chacko JG; Miller JL; Angtuaco EJ
    J Neuroophthalmol; 2010 Jun; 30(2):132-4. PubMed ID: 20393348
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intraosseous meningioma: a rare cause of chronic optic neuropathy and exophthalmos.
    Henchoz L; Borruat FX
    Klin Monbl Augenheilkd; 2004 May; 221(5):414-7. PubMed ID: 15162295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.